Unique ID issued by UMIN | UMIN000002588 |
---|---|
Receipt number | R000003164 |
Scientific Title | Clinical trial of acupuncture for diabetic peripheral neuropathy |
Date of disclosure of the study information | 2009/10/10 |
Last modified on | 2011/10/07 17:44:17 |
Clinical trial of acupuncture for diabetic peripheral neuropathy
Clinical trial of acupuncture for diabetic peripheral neuropathy
Clinical trial of acupuncture for diabetic peripheral neuropathy
Clinical trial of acupuncture for diabetic peripheral neuropathy
Japan |
Diabetic Peripheral Neuropathy
Endocrinology and Metabolism |
Others
NO
To evaluate efficacy and safety of electroacupuncture on peripheral diabetic neuropathy.
Safety,Efficacy
Exploratory
Pragmatic
Phase I,II
Severity of numbness/pain in the extremities which was evaluated with a visual analog scale (VAS).
Severity of the symptom with a faces scale, McGill-Melzack Pain Questionnaire (MPQ), SF-36 (QOL), Profile of mood status (POMS), Nerve conduction velocity, sensory threshold (Semmes-Weinstein Monofilament test), Autonomic nerve function, Vibratory sensation threshold.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Electroacucpuncture (3/20Hz) will be performed on upper and/or lower extremities once a week for seven consecutive weeks.
Not applicable |
Not applicable |
Male and Female
1) Patients who are diagnosed as Type1 or Type2 diabetes and have numbness/pain in the extremities.
2) Obtaining written informed consent.
3) No severe disfunction in the: liver, kidney, respiration and hematopoietic system.
1) Patient who have any one of the following conditions;
# neuropathic disorder such as sciatica
# symptoms considered to be related with peripheral entrapment neuropathy such as tarsal tunnel syndrome.
# Sensory disturbance related with cerebrovascular disease.
# Disturbance in the peripheral circulation such as Raynaud's disease or arteriosclerosis obliterans (ASO).
2) Severely uncontrolled blood glucocse (HbA1c=>10%).
3) Currntly pregnant or possibility of pregnancy.
4) Psychiatric disordes or any kind of cognitive dysfunctions that make understanding of the participation to the trial difficult.
5) Other conditions that are not considered eligible by the physician.
20
1st name | |
Middle name | |
Last name | Toshinori Ito |
Osaka University Graduate School of Medicine
Department of Complementary and Alternative Medicine
2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
06-6879-3498
1st name | |
Middle name | |
Last name | Toshinori Ito |
Osaka University Graduate School of Medicine
Department of Complementary and Alternative Medicine
2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
06-6879-3498
juki@CAM.med.osaka-u.ac.jp
Department of Complementary and Alternative Medicine, Osaka University Graduate School of Medicine
None
Self funding
None
None
None
NO
2009 | Year | 10 | Month | 10 | Day |
Unpublished
Enrolling by invitation
2009 | Year | 10 | Month | 01 | Day |
2009 | Year | 10 | Month | 01 | Day |
2011 | Year | 06 | Month | 01 | Day |
2009 | Year | 10 | Month | 06 | Day |
2011 | Year | 10 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003164